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ABSTRACT 
 
 
 
 
Davidson, Molly Elizabeth.  M.S., Department of Pharmacology & Toxicology, Wright 
State University, 2007.  Neurodegeneration and Neuroinflammation in a Mouse Model of 
Sarin Exposure. 
 
 
 
Sarin is an organophosphorus (OP) ester chemical warfare agent (CWA) that has 
been used in past terrorist attacks.  It remains a threat today because of its ease of 
manufacture and dispersal.  Sarin acts by irreversibly inactivating acetylcholinesterase 
and interfering with neurotransmission by allowing acetylcholine to build up at neuro-
effector junctions, where it continuously elicits a response.  Symptoms of sarin toxicity 
include seizures, hypersecretions, respiratory distress and death in extreme cases.  
Previous studies on OP poisoning indicate that sarin exposure causes neurodegeneration 
and neuroinflammation in conjunction with seizure activity.  In order to determine the 
mode of neuronal death and the extent of neuroinflammation induced by sarin exposure, 
C57Bl/6J mice were first dosed s.c. with 1.5 mg/kg cresylbenzodioxaphosphorin oxide 
(CBDP) to inhibit the large amount of carboxylesterase found in rodents. One hour later, 
mice were dosed with 24 μg/kg sarin, a dose which produces approximately 17% 
lethality.  One group of mice was also dosed with 1.7 mg/kg 8-hydroxy-2-(di-n-
propylamino)tetralin (8-OH-DPAT), a 5-HT1A receptor agonist, which has been shown 
by others to decrease different types of neuronal injury.  Mice were sacrificed at times 
 iv
ranging from four hours to ten days after sarin administration and left or right brain 
hemispheres were collected and frozen in isopentane for histological examination.  To 
detect DNA fragmentation, 10μm-thick sections were TUNEL-stained using the 
NeuroTACS II in situ apoptosis detection kit.  Activated caspase-3 and interleukin-1β 
(IL-1β) were detected by immunohistochemistry to determine whether apoptotic cell 
death and neuroinflammation were occurring.  Manual cell counts were performed on 
micrographs of dentate gyrus and CA1 regions of hippocampus, amygdala and piriform 
cortex in NIH Image.  Statistically significant TUNEL labeling was observed at various 
time points in all brain regions except CA1 hippocampus.  Significant increases in 
caspase-3 staining were observed only in piriform cortex and CA1 hippocampus at 24 
hours and four days post-sarin injection, respectively.  IL-1β expression was significantly 
increased in CA1 hippocampus at four days after sarin injection and in all brain regions 
except piriform cortex at ten days after sarin exposure.  Neither TUNEL nor caspase-3 
labeling were significantly decreased with 8-OH-DPAT treatment.  The amygdala and 
dentate gyrus regions showed significant decreases in IL-1β expression after 8-OH-
DPAT treatment.  Statistically non-significant upward trends over time in TUNEL 
labeling and IL-1β expression were observed.  In contrast, caspase-3 expression exhibited 
a gradual, non-significant decrease at later time points.  These trends may be indicative of 
a decreasing role played by apoptotic cell death and an increasing or persisting role for 
oncotic cell death and inflammation in sarin neurotoxicity.
 v
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STATEMENT OF THE PROBLEM 
 
 A growing body of evidence indicates that sarin exposure causes neurotoxic 
responses including neuronal death and inflammation.  An understanding of the 
mechanisms of sarin toxicity and development of new therapeutics for protection against 
the resultant damage are of great importance for the protection of soldiers and the general 
population in the event of a terrorist attack using organophosphates.  This study employs 
a C57BL/6J mouse model dosed with cresylbenzodioxaphosphorin oxide (CBDP) to 
inhibit the endogenously high carboxylesterase activity which is common among rodents.   
These mice were then given a single injection of sarin.  The mice were euthanized 4 
hours to 10 days (240 hours) following sarin exposure and brain tissue was collected for 
histo-pathological staining to answer the following three questions: what is the extent of 
1) neurodegeneration and cell death and 2) neuro-inflammation in this model of sarin 
toxicity?, and 3) does 8-OH-DPAT provide a potential therapeutic option in the event of 
sarin exposure?   
   
I.  INTRODUCTION 
THE HISTORY OF SARIN 
Sarin is an organophosphorus (OP) ester that irreversibly inhibits 
acetylcholinesterase (AChE).   Sarin (O-isopropyl methylphosphonofluoridate) was used 
as a chemical warfare agent (CWA) by Iraq during the Gulf War and is a continuing 
terrorist threat in the current global climate.  Sarin, whose NATO designation is GB, is  
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FIGURE 1.  Chemical Structure of Sarin (O-isopropyl methylphosphonofluoridate):  
Sarin is a colorless, odorless liquid that readily evaporates at room temperature.  
Exposure can occur by ingestion, inhalation of vapors, or by cutaneous contact with the 
liquid.  All three routes of exposure can result in symptoms of sarin toxicity.   
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one member of a group of nerve agents that includes tabun, soman, VX and CMPF.  
Originally synthesized during the 1930s and 1940s by German scientists, these agents 
were developed as chemical weapons during WWII (Agency for Toxic Substances and 
Disease Registry, 2003).  Sarin is a colorless, odorless liquid that can elicit toxic effects 
following cutaneous exposure, ingestion and/or inhalation of vapors (see Figure 1 for 
chemical structure).  The dangerous potential of this agent was realized in June 1994 
in an attack in Matsumoto, Japan and again in March 1995 during the sarin subway attack 
in Tokyo, Japan in which twelve people were killed, fifty seriously injured, and 5500 
with less severe injuries as a result of exposure to the gas (Okumura et al., 1998).  
Somewhat effective therapeutic regimes against sarin do exist, including prophylactic 
treatment and rescue treatment immediately following exposure.  However, use of these 
therapies is problematic, as prophylactic treatments must be given prior to exposure and 
the rescue treatments must be administered very quickly after exposure and before the 
onset of severe symptoms in order to be effective.  The current treatment regime is three-
fold involving 1) decontamination of victims to eliminate further exposure to the agent; 
2) respiratory support to prevent lung failure as necessary; and 3) pharmaceutical 
treatment with an oxime to prevent permanent binding of AChE by the agent and an anti-
epileptic drug to prevent neural damage as a result of seizures (Tokuda et al., 2006).  The 
threat of terrorist activity in volatile countries coupled with the ease of manufacture and 
unsophisticated release of sarin highlights the need for the development of therapeutics 
that can be used prophylactically or as rescue treatments to prevent or decrease the 
damage caused in the event of an OP CWA attack. 
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EFFECTS OF SARIN EXPOSURE 
Sarin irreversibly inhibits acetylcholinesterase (AChE), the enzyme responsible 
for degrading acetylcholine (ACh).  The mechanism for this action is sarin binding to the 
serine residue within the active motif of AChE.  Once bound, sarin is dealkylated leaving 
behind a phosphate group that cannot be removed.  Most of the clinical signs and 
symptoms of sarin poisoning occur as a result of this AChE inhibition and the subsequent 
accumulation of ACh at neuroeffector junctions.  ACh is a neurotransmitter that is active 
throughout both the central and peripheral nervous systems (CNS and PNS).  ACh is 
responsible for synaptic transmission at autonomic parasympathetic and sympathetic 
neuroeffectors in addition to somatic neuroeffectors.  As a result of its wide-ranging 
influence, interference with proper ACh function has very important physiological 
consequences.  When released from a pre-synaptic nerve terminal ACh moves across the 
synapse in vesicles to the post-synaptic nerve where it is released from the vesicle, binds 
cholinergic receptors, is quickly released, and then hydrolyzed by AChE, which 
effectively inactivates the neurotransmitter (Figure 2).  However, when AChE is 
inhibited, as in the case of OP poisoning, the ACh remains at the nerve terminal 
continuously binding receptors and eliciting a response from the post-synaptic nerve.  
Seizures, convulsions, and brain damage resembling status epilepticus are the acute 
symptoms of this hyper-stimulation (Hoskins et al., 1986; Gupta et al., 1987; McLean et 
al., 1992).  More severe symptoms include respiratory distress, paralysis and coma.  If 
these symptoms are not treated quickly they can be fatal.  The therapeutic window for 
sarin treatment is limited due to the irreversible inhibition of AChE within approximately  
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FIGURE 2.  Cholinergic Synaptic Transmission: Acetylcholine is synthesized within the 
pre-synaptic nerve from acetate and choline, then packaged in vesicles.  Upon Ca2+ influx 
into the pre-synaptic nerve, the vesicles are exocytosed and travel across the synapse to 
the post-synaptic nerve where ACh is released, binds cholinergic receptors, elicits a 
response and is then quickly released.  Normally, AChE very quickly hydrolyzes ACh 
into its original components, which are continuously recycled.  However, sarin 
irreversibly binds AChE, preventing the enzyme from hydrolyzing ACh in the synaptic 
cleft.  The neurotransmitter continues to elicit a response from the post-synaptic nerve, 
causing seizures, convulsions, respiratory distress, neuronal damage, and possibly death 
if left untreated.      
 5
45 minutes of exposure.  The brain regions most affected by sarin exposure are those 
involved in seizure activity including the hippocampus, amygdala and piriform cortex. 
 
PROLONGED EFFECTS OF SARIN EXPOSURE 
In addition to the acute symptoms, longer periods of seizure activity, due to 
extended exposure, exposure to high concentrations of sarin, and/or lack of therapeutic 
intervention, have been correlated with increased brain damage in animal models (Tanaka 
et al., 1996).  For example, Chapman and colleagues (2006) studied the expression of 
inflammatory cytokines IL-1β, IL-6, TNF-α and prostaglandin E2 in conjunction with 
length of sarin-induced seizure activity.  Their work showed that early treatment with 
midazolam (an anti-epileptic drug) during seizures can decrease the amount of 
inflammatory cytokines found in the tissue in a time-dependent manner.  Additionally, an 
increased presence of proinflammatory cytokines, activated astrocytes and microglia, and 
dead or dying neurons have been noted in animals exposed to sarin and other OPs 
(Henderson et al., 2002; Svensson et al., 2001; Williams et al., 2003; Chapman et 
al.,2006).  Henderson and coworkers observed a correlation between increasing 
inflammatory cytokine mRNA levels (IL-1β, TNF-α, and IL-6) and higher doses of sarin 
in their study on rats (2002).  The presence of these inflammatory factors implies that 
there may be additional mechanisms of toxicity, or that the toxicity of the AChE 
inhibition is potentiated by neuroinflammation.  Furthermore, neurodegeneration and cell 
death have been observed in animals exposed to sarin and other OPs.  Fluoro-Jade 
positive neurons have been detected in the brain tissue of animals exposed to sarin and 
other nerve agents, but this stain is nonspecific in regard to the type of cell death (i.e. 
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oncosis vs. apoptosis) (Carlson and Ehrich, 2004).  Further exploration is necessary in 
order to determine what mode of cell death is occurring as a result of exposure to nerve 
agents.  It is worthwhile to pursue these potential contributors to the toxicity of OPs since 
the elucidation of specific and/or additional mechanisms may lead to the discovery of 
more effective therapies. 
 
MECHANISMS OF CELL DEATH 
Previous animal studies of OP exposure have shown indications of neuronal cell 
death resulting from nerve agent toxicity.  For example, a genomic study on rats 
performed by Damodaran and colleagues showed an increase in the production of 
caspase-6 and proapoptotic Bcl2lll (a member of the Bcl family) mRNA at only 2 hours 
following sarin exposure (2006).  The early up-regulation of these genes indicates that 
apoptosis may indeed be a downstream result of sarin toxicity.  There are two main forms 
of cell death: apoptosis and oncosis.  Apoptosis is a carefully regulated process that, once 
triggered, follows a very specific and orderly cascade.  Apoptosis has recently been 
lumped together with three additional forms of actively regulated cell death; autophagic 
cell death, paraptosis and programmed necrosis (reviewed by Fietta, 2006).  Apoptosis 
and oncosis are morphologically different processes (Figure 3).  The differences between 
apoptosis and oncosis can be observed microscopically.  Apoptosis is characterized by 
shrinkage of the cell, plasma membrane blebbing, dismantling of the cytoskeleton, 
chromatin condensation and cleavage of DNA into segments of multiples of 180bp in 
length.  In the final stages of apoptosis, the cellular contents are packaged into apoptotic  
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FIGURE 3.  Morphological Features of Oncotic and Apoptotic Cell Death:  Oncotic cells 
can be identified by their loss of membrane integrity, blebbing, swelling, mitochondrial 
shrinkage, and destruction of DNA.  Apoptotic cells, on the other hand, maintain 
membrane integrity, shrink in size, undergo orderly cleavage of DNA, and form enclosed 
apoptotic bodies which then are phagocytized by neighboring microglia without the 
induction of an inflammatory response.   
 8
bodies which are then phagocytized by neighboring macrophages (microglia within 
neuronal tissue) (Wyllie, 1997).  The apoptotic process is very precise and does not often 
interfere with the condition of neighboring cells (Wyllie, 1981).  In contrast, oncosis can 
induce an inflammatory reaction as a result of leakage of proinflammatory cytokines into 
the extracellular space (Wyllie, 1997).  Oncosis is characterized by the following 
features: loss of plasma membrane integrity and leakage of cellular contents, cytoplasmic 
expansion, swelling of the endoplasmic reticulum, shrinkage of mitochondria, clumping 
of nuclear chromatin and disorderly destruction of DNA (Majno and Joris, 1995).   In 
addition to the microscopically observable characteristics of these two forms of cell 
death, there are also molecular traits that can be used to distinguish between apoptosis 
and oncosis.  Apoptosis has been identified by the presence of cleaved poly-ADP ribose 
polymerase (PARP), activated forms of the effector caspases (3, 6 and 7), the appearance 
of a DNA ladder in gel electrophoresis, terminal deoxynucleotidyl transferase-mediated 
biotinylated UTP nick end labeling (TUNEL), and numerous other molecular techniques.  
However, most of the techniques listed above are not unique to apoptosis or oncosis, 
therefore it is necessary to use complimentary methods to assess the type of death 
undergone by cells.  Caspases are the exception to this rule, as they act as the initiators 
and effectors of apoptosis, and are not active during oncosis.  This makes them an 
excellent marker for the identification of apoptotic cells. Caspases are cysteine proteases 
that cleave proteins after aspartic acid; they are present as inactive zymogens 
(procaspases) in all cells, and become activated when they are cleaved into smaller 
subunits.  The apoptotic process is carried out by a cascade of caspases, which begins 
with either an external or internal trigger for the initiation of cell death (Figure 4).  
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Externally, cell death is initiated by the extracellular binding of a cell death ligand to a 
death receptor on the surface of the cell.  This membrane-bound receptor’s internal death 
domain then activates caspase-8, thus initiating the caspase cascade.  Apoptosis can be 
initiated intrinsically by either mitochondrial dysfunction or endoplasmic reticulum (ER) 
stress.  Upon mitochondrial dysfunction there is a release of cytochrome c into the 
cytoplasm.  This triggers Apaf-1 binding with procaspase-9, cleavage of procaspase-9 
into its active form, and downstream activation of caspase-3, the first of the effector 
caspases to be triggered.  In the event of ER stress, the unfolded protein response (UPR) 
is invoked in an attempt to alleviate the buildup of unfolded proteins.  If ER stress 
continues for an extended period of time and the UPR cannot overcome it, the cell will be 
committed to die by apoptosis through the expression of Bax and JNK.  After 
commitment there is downstream formation of the apoptosome complex and a parallel 
induction of the mitochondrial apoptosis pathway by cytochrome c release (Smith and 
Deshmukh, 2007).  The extrinsic and intrinsic pathways converge at caspase-3, making 
this an ideal biomarker to determine whether or not apoptosis is occurring, regardless of 
the initial trigger for death.  TUNEL labeling in conjunction with detection of activated 
caspase-3 provides sufficient evidence of apoptosis.  This study will focus on the 
presence of apoptotic cell death and inflammation occurring in the brains of mice 
exposed to sarin.   
 
EFFECTORS AND MARKERS OF THE NEUROINFLAMMATORY RESPONSE 
Microglia are the primary immune cells within the brain and act as phagocytes to 
remove the debris when neighboring cells die.  Microglia are also responsible for the  
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FIGURE 4.  Extrinsic and Intrinsic Apoptotic Pathways: Apoptosis can be initiated 
extrinsically by binding of a death ligand to a membrane-bound death receptor (i.e. Fas 
ligand and TNF receptor.)  Within the cell, apoptosis can be initiated by mitochondrial 
release of cytochrome c, or by persistent ER stress and subsequent activation of Bax and 
JNK.  All three initiators trigger activation of caspases, the effectors of apoptosis.    
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initiation of the neuroinflammatory response.  When activated, microglia release IL-1α, 
IL-1β and TNF-α, thus initiating the cytokine cascade (McGeer and McGeer, 1995).  In 
addition to the proinflammatory cytokines released by activated microglia, they also 
contribute enzymes that help carry out the inflammatory process (Wood, 2003).  Under 
normal conditions, the inflammatory process provides essential housekeeping activities, 
but when neuroinflammation persists, cytokines, chemokines, enzymes and reactive 
oxygen species can create a toxic environment for neurons (Wood, 2003).  Once the 
inflammatory cascade has been initiated by microglia, astrocytes are recruited and begin 
releasing their own inflammatory signals, further contributing to the unhealthy 
environment and leading to neuronal damage (Davies et al., 1999; Svensson et al., 2001) 
(Figure 5).   
There are many examples of correlations between seizure activity and presence of 
inflammatory markers in the brain.  For instance, in a study performed on rats by Steward 
and coworkers (1991) electrically induced seizures caused an increase in glial fibrillary 
acidic protein (GFAP) mRNA expression, indicative of activated astrocytes resulting 
from inflammation in brain and post-synaptic regions stimulated by the seizure activity.  
In addition, Damodaran and colleagues observed up-regulation of GFAP and IL-10 
mRNA in a rat model two hours after exposure to sarin, suggesting the presence of an 
early inflammatory response accompanied by an anti-inflammatory counteraction (2006).  
Similarly, Tu and Bazan (2003) noted an increase in neuronal COX-2 expression, which 
plays an important role in inflammation, in their model of hippocampal kindling (based 
on the premise that repeated induction of low-intensity seizures decreases the threshold 
for induction of future seizures).  These studies indicate that excessive brain stimulation  
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FIGURE 5.  Neural Inflammatory Response: Microglia initiate the neuroinflammatory 
response by releasing proinflammatory cytokines (i.e. IL-1α, IL-1β and TNF.)  These 
proinflammatory signals then trigger activation of astrocytes, which begin releasing 
additional inflammatory signals.  Prolonged neuroinflammation creates a toxic 
environment for neurons eventually leading to degeneration and death.   
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initiates inflammatory processes.  Additionally, Zimmer and colleagues (1997) found that 
seizures caused by soman increased the presence of activated astrocytes and microglia in 
several brain regions including the piriform cortex, amygdala and hippocampus.  It 
follows that sarin-induced seizures may also cause neuroinflammation as a result of 
overstimulation of specific brain regions, and that this inflammatory activity may cause 
ancillary damage to surrounding neurons, thus having a long-lasting impact on brain 
function.   
IL-1β is an effective biomarker for inflammation.  According to a 2004 study by 
Basu and colleagues, blocking IL-1 activity with a receptor antagonist effectively reduces 
the amount of neuronal damage that occurs as a result of stroke.  This is significant 
because a great deal of the brain damage associated with stroke occurs as a result of 
reperfusion toxicity and the ensuing inflammatory response (Basu, et al., 2005).  The role 
of microglia as the only resident immune cells within the brain and as the initiators of the 
inflammatory response therein indicates that their early release of IL-1β is one of the very 
first steps in the inflammatory cascade.  Therefore, the presence of IL-1β in the brain 
tissue of an animal model is indicative of an ongoing inflammatory response within that 
tissue.   
 
AGONIST 8-OH-DPAT POTENTIAL THERAPY: SEROTONIN1A 
 Serotonin1A (5-HT1A) receptors are localized in brain regions that are particularly 
susceptible to excitotoxic injury, including hippocampus and cortex (Chalmers and 
Watson, 1991; Nyakas et al., 1997).  The 5-HT1A receptor is Gi protein-linked and once 
activated triggers an intracellular signaling pathway (Fargin et al., 1989).  Activation of 
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the 5-HT1A receptor is capable of affecting adenylyl cyclase activity, increasing 
hydrolysis of phosphoinositol and increasing potassium ion conductance in different 
experimental models (Fargin et al., 1989).  Therapeutic use of agonists of the 5-HT1A 
receptor have been reported to decrease the damage caused by different types of neuronal 
injury including ischemia, traumatic brain injury and NMDA-induced excitotoxicity 
(Ramos et al., 2004; Kline et al., 2001; Ohman et al., 2001; Oosterink et al., 2003).  
Although the exact mechanism of attenuation of neuronal damage by 5-HT1A receptor 
agonists is currently unknown, it has been hypothesized that it occurs because of a 
decrease in intracellular Ca2+ (Colino and Halliwell, 1987; Liu and Albert, 1991; Prehn et 
al., 1993).  This hyperpolarization of neurons decreases their capacity to fire, hence 
attenuating seizure activity and the subsequent neuronal damage.  Another potential 
mechanism of action is the inhibition of glutamate release by the activation of 5-HT1A 
receptors (Srkalovic et al., 1994.)  Glutamate is the primary excitatory amino acid in the 
brain.  It is responsible for the continuous activation of NMDA receptors that initiates 
excitotoxicity.  A third possible mechanism of 5-HT1A receptor agonists is the activation 
of the MEK/ERK signaling pathway.  Adayev and colleagues (1999) proposed that the 
activation of the MEK/ERK signaling pathway through 5-HT1A receptors could prevent 
the activation of caspase-3, thereby inhibiting apoptosis, one of the potential endpoints of 
neurotoxicity.  The mechanism proposed by Adayev may account for a decrease in cell 
death resulting from excitotoxicity, but it does not explain a decrease in the 
neuroinflammatory response. Based on the known link between seizure activity and the 
induction of an inflammatory response, the two former explanations (neuronal 
hyperpolarization and attenuation of glutamate release) could account for a decrease in 
 15
inflammation as a result of 5-HT1A agonism.  The drug 8-hydroxy-2-(di-n-
propylamino)tetralin (8-OH-DPAT) is a selective agonist of the 5-HT1A receptor.  This 
drug has been shown to decrease neuronal death in vitro under anoxic conditions and in 
vivo under excitotoxic conditions (Adayev et al., 1999; Oosterink et al., 2003).  In 
addition, 8-OH-DPAT decreased neuronal death and neuroinflammation in vivo 
following ischemic brain damage in a rat model (Ramos et al., 2004.)  The current study 
will examine the effectiveness of 8-OH-DPAT against inflammation and apoptotic cell 
death in the brains of mice exposed to a single s.c. injection of the nerve agent sarin.     
               
CARBOXYLESTERASE SCAVENGER: CBDP 
Rodents have a great deal of carboxylesterase that inactivates OPs before they can 
interact with AChE to produce the classical symptoms of OP poisoning.  Cresylbenzo-
dioxaphosphorin oxide (CBDP) is a carboxylesterase inhibitor.  CBDP scavenges excess 
rodent carboxylesterase and effectively increases the animals’ susceptibility to OP 
poisoning, making their exposure at low doses more representative of human exposure.  
Application of CBDP decreases cross-species variability in the LD50 of sarin from 22.8-
125 μg/kg to 11.8-15.6 μg/kg (Maxwell et al., 1987).  Preliminary work has shown that a 
dose of 1.5 mg/kg CBDP does not cause toxicity alone, and potentiates the response of 
C57BL/6J mice to sarin.   
 
HYPOTHESIS 
 
The large body of evidence indicating that neuroinflammation and 
neurodegeneration are symptoms of sarin exposure and the relatively novel concept that 
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5-HT1A agonists are potentially useful at decreasing damage due to excitotoxicity lead to 
the development of the following hypothesis: exposure of mice to sublethal doses of sarin 
causes apoptosis and inflammation in brain regions susceptible to excitotoxicity; i.e., 
piriform cortex, amygdala and hippocampus.  These neuropathologic conditions can be 
attenuated by treatment with 8-OH-DPAT, a 5-HT1A receptor agonist.  The objective of 
this study was two-fold: 1) to confirm that neurodegeneration and neuroinflammation 
occur in our model of sarin toxicity, which differs from other models in the use of CBDP 
as a carboxylesterase inhibitor; and 2) to determine whether these toxic responses could 
be attenuated by therapeutic use of a 5-HT1A receptor agonist.  These two objectives were 
divided based on the symptoms to be examined (i.e. neurodegeneration and 
neuroinflammation) into two specific aims.     
 
SPECIFIC AIM 1 
 Test the hypothesis that sarin induces apoptosis in the piriform cortex, amygdala, 
dentate gyrus and CA1 region of hippocampus, and that this neurodegeneration can be 
attenuated by a therapeutic dose of 8-OH-DPAT.  
 
SPECIFIC AIM 2 
Test the hypothesis that sarin induces an inflammatory response in the piriform 
cortex, amygdala, dentate gyrus and CA1 region of hippocampus, and that the 
neuroinflammation can be attenuated by a therapeutic dose of 8-OH-DPAT.   
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II.  MATERIALS & METHODS 
 
DRUGS 
 
CBDP was delivered in propylene glycol and 5% ethanol at a concentration of 
0.15mg/mL.  Mice were dosed with 1.5 mg/kg CBDP 1 hour prior to receiving a dose of 
sarin.  Sarin was diluted from a stock of 1.9 mg/mL in saline solution (original stock 
obtained from Aberdeen Proving Ground, MD).  Sarin was injected in a volume of 1 
mL/100 g weight to obtain a dose of 24µg/kg.  8-OH-DPAT (Sigma, St. Louis, MO) was 
dissolved in 0.9% saline and given at a dose of 1.7mg/kg 1 minute after sarin injection.  
All injections were subcutaneous (s.c.). 
 
ANIMALS 
 
Male C57BL/6J mice at 20-25g body weight were used in this study.  The mice 
were housed in an AAALAC (Association for the Assessment and Accreditation of 
Laboratory Animal Care) approved facility on a 12 hour light/dark cycle with free access 
to food and water.  Six groups of mice received different treatments: Group 1, the 
negative control group received propylene glycol and saline (vehicles for CBDP and 
sarin, respectively) and were euthanized four or ten days (240 hours) after injection; 
Groups 2, 3, 4 and 5 received CBDP and sarin and were euthanized four, 24, 96 and 240 
hours after injection, respectively; and Group 6 received CBDP, sarin and 8-OH-DPAT 
and were euthanized 240 hours (10 days) after injection.  (See Table 1 for n values of 
each group.)   
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Group TUNEL Caspase-3 Interleukin-1β 
Negative Control 4 5 4 
4 Hours Post-Sarin 2 2 2 
24 Hours Post-Sarin 2 2 2 
96 Hours Post-Sarin 4 9 (8 Piriform) 6 
240 Hours Post-Sarin 5 (3 Amygdala) 6 (5 Amygdala)  5 
240 Hours Post-
Sarin/8-OH-DPAT 6 6 (5 Amygdala)  6 
 
TABLE 1.  Summary of n Values of Experimental Groups:  n-values for each group and 
each staining technique are stated.  Values were the same across all brain regions 
examined except where stated specifically for individual regions.  
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TISSUE COLLECTION AND SECTIONING 
 
Following treatment, mice were sacrificed by decapitation after CO2 knockout and 
brain tissue was collected for histology.  Brains were removed and separated into left and 
right hemispheres.  One half of each brain was quick frozen in isopentane for 30 seconds 
and then stored at -80°C until sectioning.  Brain tissue was mounted on a cryotome 
chuck, covered with tissue freezing medium (Triangle Biomedical Sciences, Durham, 
NC), and coronally sliced on a cryotome (at approx. -20°C) at 10μm thickness throughout 
brain regions inclusive of amygdala, hippocampus, and piriform cortex.  Sections were 
collected on UltraStick slides (Gold Seal Products, Portsmouth, NH) and stored at -20°C 
until fixed for staining.  
 
FLUORO-JADE C STAINING 
Tissue sections affixed to slides were placed in 1% NaOH/80% ethanol for 5 
minutes at room temperature, then in 70% ethanol for 2 minutes  Slides were rinsed in 
deionized water for 2 minutes.  Potassium permanganate solution (0.06% in deionized 
water) was applied to sections for 10 minutes.  Slides were then rinsed in tap water for 2 
minutes.  Dilute Fluoro-Jade C (0.0001% in acetic acid vehicle [Chemicon International, 
Temecula, CA]) was applied to sections and incubated in the dark at room temperature 
for 10 minutes.   Sections were rinsed with deionized water 3 times, 1 minute each.  
Slides were allowed to dry on a slide warmer at approximately 50°C for 5 minutes, then 
cleared for 1 minute in HistoChoice clearing agent (Sigma, St. Louis, MO).  Coverslips 
were mounted with DPX mounting medium (Fluka, Buchs, Switzerland) and stored in the 
dark until microscopic analysis.  
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TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE-MEDIATED 
BIOTINYLATED UTP NICK END LABELING (TUNEL)  
 
TUNEL staining was performed on brain sections using the NeuroTACS II In Situ 
Apoptosis Detection Kit (Trevigen, Gaithersburg, MD).  The assay protocol provided by 
the manufacturer was followed with the addition of three steps to optimize staining.  
After rehydration in alcohols, lipids were extracted from the brain tissue sections by 
dipping slides in chloroform for 5 seconds, then incubating at room temperature for 10 
minutes in methanol, followed by washing twice in 1X PBS for 5 minutes each.  Next, 
the sections were fixed in 3.7% buffered paraformaldehyde for 10 minutes.  After this 
step the kit protocol was followed with the exception of an additional wash after the 10 
minute incubation in Strep-HRP solution.  Samples were washed twice in 1X PBS 
containing 1% BSA and 0.05% Tween-20.  The counterstaining step was omitted.  Slides 
were allowed to dry and coverslipped with Permount (Fisher, Pittsburgh, PA) mounting 
medium.     
   
CASPASE-3 IMMUNOFLUORESCENT STAINING 
 
Prior to staining, tissue sections were fixed to glass slides by incubating for 15 
minutes in 3.7% buffered paraformaldehyde.  After fixation, slides were washed three 
times for 5 minutes in 1X PBS and blocked for 1 hr. in 10% normal horse serum (diluted 
in 1X PBS/0.02% Triton X-100).  The primary antibody, anti-cleaved caspase-3 rabbit 
polyclonal antibody (Cell Signaling Technology, Boston, MA), which detects only the 17 
kDa subunit of activated caspase-3, was diluted to 1:250 in 1X PBS, applied to sections, 
and incubated overnight at 4°C in a humid chamber.  Primary antibody was removed and 
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sections washed as described above.  The secondary antibody, Biotin-SP conjugated 
Donkey anti Rabbit (Jackson Immunoresearch Laboratories, West Grove, PA), was 
diluted 1:500 in 1X PBS and incubated on tissue-fixed slides for 1 hour at room 
temperature in the dark.  Secondary antibody was removed and sections were washed 
three times for 5 minutes each in 1X PBS.  The third antibody, streptavidin conjugated 
Cy 3, was diluted 1:200 in 1X PBS, and incubated with the tissue-fixed slides for 1 hour 
at room temperature in the dark.  After removal of the third antibody, sections were 
washed as described above then incubated with 0.01 mg/mL Hoechst stain (H3569, 
Invitrogen, Eugene, OR) for 10 minutes at room temperature in the dark.  Hoechst stain 
labels all nuclei and allows for the visualization of brain structures.  Sections were 
washed in deionized water for several minutes and coverslips were mounted with Gel 
Mount mounting medium (Biomeda, Foster City, CA).  
 
INTERLEUKIN-1β IMMUNOFLUORESCENT STAINING 
 
Tissue-fixed slides were stained for IL-1β as described above for caspase-3 
staining with the exception of using a primary rabbit polyclonal antibody against IL-1β, 
diluted 1:1000 (sc-7884 from Santa Cruz Biotechnology, Santa Cruz, CA).   
 
 
IMAGE CAPTURE 
 
All fluorescently stained sections were viewed on a Leica DMR microscope under 
the fluorescein isothiocyanate (FITC) filter or rhodamine filter set.  Hippocampus 
(dentate gyrus and CA1 regions), amygdala and piriform cortex regions (Figure 6) of 
each TUNEL, IL-1β, or caspase-3-stained section were viewed and micrographs taken at 
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20X magnification using an Optronics Magnafire CCD camera with MagnaFire software 
v.2.0 (Optronics, Goleta, CA).             
 
DATA/STATISTICAL ANALYSIS 
 
Micrograph images were opened in NIH ImageJ v.1.37 and positively labeled 
cells within defined areas were counted using the cell counter plug-in.  Areas for 
amygdala, piriform cortex and CA1 regions were 450µm x 450µm, while areas for 
dentate gyrus counts were 450µm x 275µm.  In most cases, TUNEL labeling of only one 
section per animal was counted, whereas for caspase-3 and IL-1β, staining of two 
sections per animal was assessed.  There were exceptions to this when sections were 
damaged during processing and/or brain regions were indistinguishable, preventing 
accurate cell counts (see Appendix for details of TUNEL, caspase-3 and IL-1β staining).  
Cell counts were uploaded into GraphPad Prism v.4.03 software where one-way ANOVA 
and Tukey-Kramer post-hoc test (with correction for groups of different sizes) were 
performed.  P values of less than 0.05 were accepted as significant.  All values are 
reported as mean ± standard deviation.  Refer to Table 1 for n values of each 
experimental group. 
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FIGURE 6. Brain Regions of Interest: Amygdala, dentate gyrus, CA1 hippocampus and 
piriform cortex regions were photographed under 20X magnification.  Labeled cells were 
counted, and counts were averaged to obtain a mean value for each group.   
 
 24
 
 
 
 
III.  RESULTS 
 
FLUORO-JADE C STAINING 
 
The presence of positive staining by Fluoro-Jade C is an indicator for cells 
undergoing neurodegeneration.  Sections of brain tissue from negative control mice 
receiving only injections of vehicle showed virtually no specific staining, i.e., 
degenerating neurons (Figure 7a).  When tissue sections from mice treated with sarin 
were stained with Fluoro-Jade C we observed a few labeled cells in the amygdala, dentate 
gyrus, CA1 region of hippocampus and piriform cortex (Figure 7b, c, and d).  Because 
this staining technique was intended only to establish evidence of neurodegeneration, 
positively labeled cells were not quantified.   
  
TUNEL STAINING 
 
TUNEL staining is a method of analyzing nuclear DNA in intact cells and is used 
as an indicator of cell death.  Based on the Fluoro-Jade C staining, we chose to examine 
the same four brain regions by TUNEL assay.  Statistical analysis of cell counts in 
amygdala, dentate gyrus, CA1 hippocampus and piriform cortex of sarin treated mice 
showed a significant increase in the number of TUNEL-positive cells compared to 
negative control tissues (from animals receiving propylene glycol and saline injections) 
(Figure 8). Specifically, a significant increase in TUNEL-labeled cells was observed in 
the amygdala four days after a 24µg/kg dose of sarin (F4, 10=4.456, p<0.05)(Figure 9a).   
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FIGURE 7.  Fluoro-Jade C Staining in Mouse Brain Tissue 4 Days After Sarin 
Treatment:  a) Dentate gyrus of a mouse treated with vehicle only at 20X magnification; 
b) CA2 region of a mouse given 32μg/kg sarin + 1.5mg/kg CBDP at 40X magnification; 
c) dentate gyrus of a mouse treated with 32μg/kg sarin + 1.5mg/kg CBDP at 20X 
magnification; and d) Dentate gyrus of a mouse treated with 32μg/kg sarin + 1.5mg/kg 
CBDP at 40X magnification.  Note that there is virtually no specific staining in the 
negative control tissue, while some Fluoro-Jade C-positive cells can be observed in the 
tissue of sarin treated mice.  Scale bars represent 100μm.    
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FIGURE 8.  TUNEL Labeling in the Dentate Gyrus: Micrographs showing representative 
TUNEL-labeled brain sections from a) negative control mouse treated with vehicle only; 
b) mouse treated with 1.5mg/kg CBDP + saline; c), d), e), and f) mice treated with 
1.5mg/kg CBDP + 24μg/kg sarin and euthanized at 4, 24, 96, and 240 hours after 
treatment, respectively; g) mouse treated with 1.5mg/kg CBDP + 24μg/kg sarin + 
1.7mg/kg 8-OH-DPAT; and h) positive control generated using TACS nuclease.  Scale 
bar represents 100μm.  Due to the inherent issues with decreasing the size of the 
photomicrographs, differences between differently treated tissues are difficult to detect 
visually, as seen in this figure.  
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FIGURE 9.  TUNEL Labeling in the amygdala, dentate gyrus, CA1 hippocampus and 
piriform cortex: The plotted values represent the mean number of TUNEL-positive cells 
± S.D. in the (a) amygdala, (b) dentate gyrus, (c) CA1 hippocampus, and (d) piriform 
cortex of mice given 24µg/kg sarin at four hours, 24 hours, four days and ten days post-
dose.  F4, 10=4.456 for amygdala, F4, 12=7.488 for dentate gyrus, F4, 12=1.963 for CA1, and 
F4, 12=3.071 for piriform cortex.  A p-value <0.05 was considered significant (* p<0.05, 
*** p<0.001).
 28
In the piriform cortex there was a significant increase in TUNEL-positive cells only four 
hours after sarin treatment (F4, 12=3.071, p<0.05; Figure 9d).  In the dentate gyrus, there 
were significant increases in TUNEL staining in sarin treated mice four hours, four days, 
and ten days post-dose (F4, 12=7.488, p<0.05; p<0.05; and p<0.001, respectively; Figures 
8c, e, f, and 9b).  The CA1 hippocampal region showed no significant increase in staining 
at any examined timepoint as a result of exposure to sarin (Figure 9c).  In order to assess 
the efficacy of the 5-HT1A agonist in preventing neuronal cell death as a result of sarin 
exposure, one group of mice was given a therapeutic dose of 8-OH-DPAT one minute 
after sarin injection.  This group of mice was euthanized 10 days after injection and 
staining was compared with the negative control tissues and with tissues from sarin 
treated mice from the same timepoint.   Treatment with 1.7mg/kg 8-OH-DPAT did not 
cause any significant decreases in TUNEL staining in any of the brain regions of interest 
at ten days post-dose (Figure 10).  
 
CASPASE-3 STAINING 
 
Caspases are cell death enzymes activated in cells destined to undergo apoptosis. 
In many cases, apoptosis is deliberate and necessary.  In other cases, apoptosis is not part 
of the pre-determined order of life for the cell and is deemed inappropriate.  When this 
occurs, the cell undergoes abnormal cell death, causing changes in the capacity of the 
tissue or organ to function normally.  Statistical analysis of the cell counts from sections 
stained for the active form (17kDa subunit) of caspase-3 indicated significant increases in 
staining over the negative control tissues (animals receiving propylene glycol and saline 
injections) only in CA1 hippocampus four days after sarin injection (F4,19=3.531, p<0.05) 
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(Figure 11c) and in piriform cortex 24 hours after sarin injection (F4,18= 5.049, p<0.05) 
(Figure 11d).  No other brain regions showed significant increases in caspase-3 activity 
with sarin exposure (Figure 12).  Animals given a therapeutic dose of 8-OH-DPAT one 
minute after sarin injection and euthanized 10 days after treatment were compared with 
negative control and sarin treated mouse tissue from the 10 day post-sarin dose time 
point.  No significant decrease in caspase-3 activity was observed as a result of treatment 
with 8-OH-DPAT, however, there were no significant increases in caspase-3 activity at 
the 10 day timepoint, so this result is not necessarily indicative of the effectiveness of 8-
OH-DPAT treatment (Figure 13).  
 
INTERLEUKIN-1β STAINING 
IL-1β is a proinflammatory cytokine whose expression is indicative of an 
inflammatory response.  Statistical analysis of IL-1β staining in the four brain regions of 
interest (Figure 14) revealed significant increases in IL-1β expression at ten days after 
sarin injection in amygdala, dentate gyrus and CA1 hippocampus (F4,14= 6.625, p<0.01; 
F4,14= 9.853,  p<0.001; and F4,14= 4.358, p<0.05, respectively) (Figure 15a, b, and c, 
respectively).  Additionally, in the CA1 region of hippocampus, there was a significant 
increase in IL-1β protein four days after sarin treatment (F4,14= 4.358, p<0.01).  The 
piriform cortex had no significant changes in IL-1β expression as a result of exposure to 
a 24µg/kg dose of sarin (Figure 15d).  The usefulness of 8-OH-DPAT treatment against 
the inflammatory consequences of sarin exposure was tested by comparing the mean 
number of IL-1β-positive cells in groups dosed with sarin plus 8-OH-DPAT, sarin alone, 
and propylene glycol plus saline (negative control) 10 days after injection.  Comparison  
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FIGURE 10.  TUNEL Labeling 10 Days after Treatment with Sarin and 8-OH-DPAT: 
Graph showing the mean number of TUNEL-positive cells in amygdala, dentate gyrus, 
CA1 hippocampus and piriform cortex ten days after treatment.  Negative control mice 
were dosed with propylene glycol and saline, sarin mice received 24μg/kg sarin, sarin/8-
OH-DPAT mice received 24μg/kg sarin and 1.7mg/kg 8-OH-DPAT.  Each bar represents 
the mean ± S.D.  F2, 10=2.736 for amygdala, F2, 12=12.77 for dentate gyrus, F2, 12=1.241 
for CA1, F2, 12=1.593 for piriform cortex.  A p-value <0.05 was considered significant (c 
= p<0.001).   
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FIGURE 11.  Temporal Changes in Caspase-3 Activity After 24μg/kg Sarin in Four 
Brain Regions: The plotted values represent the mean number of caspase-3-positive cells 
± S.D. in the (a) amygdala, (b) dentate gyrus, (c) CA1 hippocampus, and (d) piriform 
cortex of mice given 24µg/kg sarin at four hours, 24 hours, four days and ten days post-
dose.  F4,18= 1.639 for amygdala, F4,19= 0.8717 for dentate gyrus, F4,19=3.531 for CA1, 
and F4,18= 5.049 for piriform cortex.  A p-value <0.05 was considered significant (* 
p<0.05). 
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FIGURE 12.  Caspase-3 Staining in the Dentate Gyrus: Micrographs showing a) negative 
control mouse tissue treated with propylene glycol and saline; b) tissue from a mouse 
treated with 1.5mg/kg CBDP and euthanized 96 hours after treatment; c); d); e); and f) 
tissue from mice treated with 1.5mg/kg CBDP + 24μg/kg sarin and euthanized 4, 24, 96, 
and 240 hours after injection, respectively; and g) tissue from a mouse treated with 
1.5mg/kg CBDP + 24μg/kg sarin + 1.7 mg/kg 8-OH-DPAT.  Scale bar represents 100μm.  
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As in Figure 8, due to the inherent issues with decreasing the size of the photo-
micrographs, differences in staining between differently treated tissues are difficult to 
detect visually.      
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FIGURE 13.  Caspase-3 Staining 10 Days after Treatment with Sarin and 8-OH-DPAT: 
Graph showing the mean number of caspase-3-positive cells in amygdala, dentate gyrus, 
CA1 hippocampus and piriform cortex ten days after treatment.  Negative control mice 
were dosed with propylene glycol and saline, sarin mice received 24μg/kg sarin, sarin/8-
OH-DPAT mice received 24μg/kg sarin and 1.7mg/kg 8-OH-DPAT.  Each bar represents 
the mean ± S.D.  F2,12= 2.302 for amygdala, F2,14= 4.684 for dentate gyrus, F2,14= 3.253 
for CA1, and F2,14= 4.783 for piriform cortex.  A p-value <0.05 was considered 
significant.    
 
 35
of the means of each group at the ten day timepoint showed a significant decrease in IL-
1β staining in the amygdala (F2,12= 17.27, p<0.05) and in the dentate gyrus (F2,12= 18.44, 
p<0.01) of animals that received a dose of 8-OH-DPAT one minute after the sarin 
injection (Figure 16).  
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FIGURE 14.  IL-1β Staining in the Dentate Gyrus: Micrographs showing a) negative 
control mouse tissue treated with propylene glycol and saline vehicles; b) brain tissue 
from a mouse treated with 1.5mg/kg CBDP and euthanized 96 hours after treatment; c); 
d); e); and f) tissue from mice treated with 1.5mg/kg CBDP + 24μg/kg sarin and 
euthanized 4, 24, 96, and 240 hours after injection, respectively; and g) tissue from a 
mouse treated with 1.5mg/kg CBDP + 24μg/kg sarin + 1.7 mg/kg 8-OH-DPAT.   Scale 
bar represents 100μm.  As in Figure 8, due to the inherent issues with decreasing the size 
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of the photomicrographs, differences in staining between differently treated tissues are 
difficult to detect visually.      
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FIGURE 15.  Temporal Changes in IL-1β Expression After 24μg/kg Sarin in Four Brain 
Regions: The plotted values represent the mean number of IL-1β-positive cells ± S.D. in 
the (a) amygdala, (b) dentate gyrus, (c) CA1 hippocampus, and (d) piriform cortex of 
mice given 24µg/kg sarin at four hours, 24 hours, four days and ten days post-dose.  
F4,14= 6.625 for amygdala, F4,14= 9.853 for dentate gyrus, F4,14= 4.358 for CA1, and F4,14= 
1.754 for piriform cortex.  A p-value <0.05 was considered significant (* p<0.05, ** 
p<0.01, *** p<0.001).   
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FIGURE 16.  IL-1β Activity 10 Days after Treatment with Sarin and 8-OH-DPAT: 
Graph showing the mean number of IL-1β-positive cells in amygdala, dentate gyrus, CA1 
hippocampus and piriform cortex ten days after treatment.  Negative control mice were 
dosed with glycol and saline, sarin mice received 24μg/kg sarin, sarin/8-OH-DPAT mice 
received 24μg/kg sarin and 1.7mg/kg 8-OH-DPAT.  Each bar represents the mean ± S.D.   
F2,12= 17.27 for amygdala, F2,12= 18.44 for dentate gyrus, F2,12= 8.078 for CA1, and F2,12= 
3.380 for piriform cortex.  A p-value <0.05 was considered significant (a = p<0.05, b = 
p<0.01, and c = p<0.001).    
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IV.  DISCUSSION 
 
 The main objective of this study was to determine if sarin would have an adverse 
affect on specific brain regions.  Specifically, we asked two questions; 1) does sarin cause 
inappropriate cell death; and 2) does an immune response occur as a result of sarin 
exposure?  To answer these questions, we analyzed neurodegeneration and neuro-
inflammation in sarin-treated mice using four specific techniques; 1) Fluoro-Jade C 
staining for degenerating neurons; 2) TUNEL staining for degraded DNA; 3) caspase-3 
staining for cells undergoing apoptosis; and 4) IL-1β staining for cells undergoing an 
inflammatory response.   
 
NEURODEGENERATION 
 
Fluoro-Jade stain is a marker for neurons undergoing degeneration.  Schmued and 
colleagues (2005) found that the newest generation of Fluoro-Jade (Fluoro-Jade C, FJ-C) 
shows lower background and higher staining intensity than its predecessors (FJ and FJ-
B).  Therefore, we used Fluoro-Jade C in our study.  Using our C57Bl/6J mouse model of 
sarin exposure, FJ-C did not show the expected abundance of degenerating neurons.  
Some positively stained neurons were detected, particularly in the dentate gyrus at four 
days after sarin exposure, while there were a few scattered cells visible in amygdala, CA1 
hippocampus and piriform cortex.  The small number of FJ-C positive neurons visualized 
in the C57Bl/6J mouse model is consistent with the findings of McLin and Steward 
(2006), who used kainic acid (KA) to induce seizures and neurodegeneration in various 
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strains of mice and compared FJ-C staining across the different strains.  They concluded 
that, not only were the C57Bl/6 mice particularly resistant to KA-induced seizures, but 
that this strain also showed little neurodegeneration (exemplified by very little FJ-C 
staining) when compared with other strains given similar KA treatments (McLin and 
Steward, 2006).  Generally, KA-induced seizures produce similar excitotoxic neuronal 
damage to that caused by sarin-induced seizures. Seizure activity is required for the onset 
of neuronal damage in animal models of OP toxicity (Munro et al., 1994).  Despite 
limiting their samples to only mice who underwent repeated tonic clonic seizures, McLin 
and Steward (2006) still detected very little FJ-C staining in the hippocampus of C57Bl/6 
mice in comparison with other strains of mice whose neurodegeneration was far more 
pronounced (Figure 17).  Based on the results of McLin and Steward and on our own 
results, we concluded that the C57Bl/6J mouse model may not be the optimal model for 
studying the effects of sarin on neurodegeneration, specifically that measured by FJ-C.  
In our study, neurodegeneration could not be quantified using FJ-C staining due to the 
relatively small number of positively-labeled cells.  Despite the shortcomings of the 
animal model, the presence of a small number of dying neurons visualized with Fluoro-
Jade C convinced us that further pursuit of this study was warranted.  
 
TUNEL LABELING 
During apoptosis and oncosis (Dong et al., 1997) the nuclear DNA of cells can be 
cleaved into multiples of ~180 base pairs.  The TUNEL technique labels the ends of these 
cleaved nuclear DNA segments, allowing them to be identified by light microscopy. 
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FIGURE 17.  High power magnification (10X) photomicrographs of fluoro-jade stained 
tissue sections from mice of three strains: (A) C57BL/6, (B) FVB/N and (C) DBA/2J.  
Each section shows the dentate gyrus of the hippocampus of the right hemisphere.  
Portions of the CA1 and CA3 subfields are visible.  The letters ‘D’ and ‘V’ denote the 
dorsal and ventral blades of the dentate gyrus and ‘H’ is the hilus region of the dentate 
gyrus.  Degenerating cells are shown as bright punctuate points.  Scale bar, 200μm (in A, 
applies to A-C).  (Figure and associated legend are used with permission of the Editor, 
European Journal of Neuroscience.)  (McLin and Steward, 2006) 
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Since TUNEL assay can detect both apoptotic and oncotic cell death (Trump et al., 
1997), TUNEL labeling is currently used in conjunction with detection of another 
apoptosis-specific protein, i.e., caspase-3, to definitively determine apoptotic state.  The 
relatively high background staining observed in all four brain regions is likely a result of 
the small sample sizes and could potentially be alleviated by increasing the number of 
negative control animals examined or by reporting the results as percentage of total cell 
counts rather than mean cell counts.  The results of TUNEL staining of the brain tissue of 
mice indicated that the region most sensitive to sarin exposure was the dentate gyrus, 
where significant increases in staining occurred at four hours, four days and ten days after 
acute exposure.  Consistent with the report that organophosphorus ester-induced seizures 
are initiated in the piriform cortex, there was a significant increase in staining in this 
region at the four hour time point, after which the staining decreased to non-significant 
levels (McDonough and Shih, 1997).  This suggests that sarin had an effect on this region 
that was not long lasting, since more cells did not appear to be stained at later time points. 
After the initiation of seizures in the piriform cortex, other brain regions begin 
participating in the excitatory activity of the seizures as they are distally stimulated 
(McDonough and Shih, 1997).  This is in agreement with our data that showed significant 
increases in neurodegeneration in the dentate gyrus and amygdala at later time points.  
Curiously, the dentate gyrus also showed an initial significant increase in TUNEL 
staining at four hours post-sarin dose, suggesting that this region is affected early after 
acute sarin exposure.  A slight, non-significant increase in TUNEL labeling was observed 
in CA1 and piriform cortex regions, accompanied by a significant increase in the dentate 
gyrus at the ten day post-sarin dose time point, indicating that there may be an increasing 
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amount of cell death as time progresses.  Gradually increasing cell death could be the 
result of an ongoing inflammatory response in the tissue.  There may be an even greater 
increase in neurodegeneration at timepoints beyond ten days after exposure. 
 
CASPASE-3 ACTIVITY    
Apoptosis is a term that describes a complex sequence of events that ultimately 
lead to the death of a cell.  During this process, specific enzymes that reside in every cell 
are activated and digest or cleave more enzymes, other proteins and DNA, finally 
resulting in one specific enzyme, i.e., capsase-3, becoming active.  Activated caspase-3 is 
an effector molecule, responsible for carrying out the final death plans of the cell.  Since 
nearly all apoptotic cell death utilizes caspase-3, it has become the signature molecule for 
the identification of apoptotic cells.  We expected to see a unified activation of caspase-3 
accompanied by TUNEL labeling early in the process of neurodegeneration.  Both 
caspase activity and TUNEL labeling are expected to decrease as apoptotic cells die and 
are phagocytized.  Due to the relatively small n, the unexpectedly high number of 
caspase-3-positive cells observed in our negative controls may be a statistical fluke.  
Background may be decreased to expected values with analysis of a larger n, or if 
positive staining is reported as percent of total cell count.  Consistent with the 
observation that sarin-induced seizures are initiated within the piriform cortex, there was 
an early significant increase in caspase-3 activity at the 24 hour post-dose timepoint in 
that brain region (McDonough and Shih, 1997).  This is subsequent to the significant 
increase in TUNEL labeling at the four hour post-dose timepoint in piriform cortex.  This 
sequence is contrary to expectations based on the sequence of events during apoptosis, 
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where one would expect to observe simultaneous increases in effector caspase activity 
and TUNEL labeling.  The four day post-dose time point showed a significant increase in 
caspase-3 staining in the dentate gyrus, implicating its role in sarin-induced 
excitotoxicity.  In addition to the observed statistically significant caspase-3 staining, all 
four brain regions of interest showed slightly greater staining than negative controls with 
the exception of the four hour time points in the dentate gyrus and piriform cortex, 
indicating that apoptosis does play a role in neurodegeneration due to sarin exposure.  It 
appears that caspase-3 activity gradually decreases after the peak seen at either four or 24 
hours post-dose.  This is in contrast to the gradual increase in TUNEL staining that we 
observed in our model (Figure 18).  Apoptotic cells are expected to exhibit a 
simultaneous increase in effector caspase activity and DNA cleavage, rather than the 
staggered pattern observed in our data, indicating that apoptosis may play only a minor 
role in sarin toxicity. 
 
IMMUNE RESPONSE 
INTERLEUKIN-1β EXPRESSION 
 IL-1β is a proinflammatory cytokine whose expression in a cell is indicative of an 
ongoing inflammatory response.  The toxic by-products of a prolonged neuro-
inflammatory response can cause damage to nearby neurons.  As much as a 2-fold change 
of IL-1β expression was observed in the brain tissue of sarin-exposed mice.  Significant 
staining was observed first in the CA1 hippocampal region at four days after sarin 
treatment.  At the ten day time point there was a significant increase in staining over 
negative control in the amygdala, dentate gyrus and CA1 regions.  This came after a  
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FIGURE 18.  Comparison of TUNEL and Caspase-3 Labeling:  The plotted values 
represent the mean number of Caspase-3 and TUNEL-positive cells in the (a) amygdala, 
(b) dentate gyrus, (c) CA1 hippocampus, and (d) piriform cortex of mice given 24µg/kg 
sarin at four hours, 24 hours, four days and ten days post-dose.  Caspase-3 data points are 
represented by circles and TUNEL data points are represented by squares.  Note the 
gradual decrease in caspase-3 activity observed at the later time points in all four brain 
regions.  This is in contrast with the gradual increase in TUNEL labeling seen in all 
regions except the amygdala.  The lack of agreement between these two staining 
techniques indicates that apoptosis is not the only type of cell death occurring in this 
animal model of sarin toxicity.    
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FIGURE 19.  Comparison of TUNEL and IL-1β Labeling:  The plotted values represent 
the mean number of IL-1β and TUNEL-positive cells in the (a) amygdala, (b) dentate 
gyrus, (c) CA1 hippocampus, and (d) piriform cortex of mice given 24µg/kg sarin at four 
hours, 24 hours, four days and ten days post-dose.  TUNEL data points are represented by 
triangles and IL-1β data points are represented by squares.  Note the gradual increase in 
TUNEL staining at the later time points in all regions except amygdala, and the 
corresponding gradual increase in IL-1β expression at later time points in all regions 
except CA1 hippocampus.  This is indicative of the ongoing neurodegeneration and 
inflammatory response occurring in the tissue as late as ten days after a single exposure 
to sarin.  (TUNEL data repeated from Figure 18.) 
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gradual increase in staining over time that was not statistically different at the earlier time 
points.  Observation of this increasing IL-1β expression is indicative of the initiation of 
an inflammatory response in the tissues affected by sarin exposure.  Of particular interest 
is the observation of a significant decrease in IL-1β expression (from the sarin treated 
mice) in the amygdala and dentate gyrus ten days after treatment with sarin and the 5-
HT1A receptor agonist 8-OH-DPAT.  This is a direct indication that there is a decrease in 
inflammation after sarin exposure with 8-OH-DPAT treatment in these two regions of the 
brain.  Based on the potential mechanisms of 5-HT1A receptor agonist efficacy, and the 
known progression of sarin-induced seizure activity, the most likely explanation for 8-
OH-DPAT’s anti-inflammatory effect is its decrease of glutamate release (Srkalovic et 
al., 1994).  Since glutamatergic stimulation of NMDA receptors is a primary culprit in 
ongoing seizure activity (McDonough and Shih, 1997), prevention of glutamate release 
decreases or ends seizure activity, thereby attenuating the resultant neuroinflammation.     
Also of interest is the gradual increase in IL-1β expression over time in the 
amygdala, dentate gyrus and piriform cortex (Figure 19).  This correlates with the 
observed increase in TUNEL labeling and contrasts with the decrease in caspase-3 
activity.  This could be indicative of an increase in oncotic cell death, while apoptotic cell 
death is decreasing over time.  The increasing presence of IL-1β corresponds with the 
fact that oncotic cell death causes an inflammatory reaction in local tissue.  An alternative 
explanation is that the cells expressing IL-1β have been damaged by the acute sarin 
exposure, but are in the process of recovering from the insult, and the inflammatory 
response is a protective repair mechanism.     
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CONCLUSIONS 
 Exposure to a single s.c. injection of sarin causes neurotoxicity in C57Bl/6J mice 
given a dose of 1.5 mg/kg CBDP, a carboxylesterase scavenger.  Neuronal excitotoxicity 
occurs as a result of sarin’s irreversible binding of acetylcholinesterase (McDonough and 
Shih, 1997).  The resultant cholinergic activity initiates seizures which are further carried 
on by glutamatergic stimulation of NMDA receptors (McDonough and Shih, 1997).  This 
excitatory activity results in neuroinflammation and neuronal death (Chapman et al., 
2006; Svensson et al., 2001; Abdel-Rahman et al., 2002).  Apoptosis and oncosis likely 
both contribute to neuronal loss in our model of sarin toxicity.  The dentate gyrus 
exhibited the greatest sensitivity to sarin, indicated by increased cell death.  The 
amygdala and piriform cortex regions exhibit similar sensitivity to sarin, lower than that 
of the dentate gyrus, as indicated by TUNEL staining, whereas the CA1 hippocampal 
region is not significantly affected by sarin exposure.  The temporal sequence of TUNEL 
and caspase-3 staining indicates that apoptotic cell death is certainly occurring as a result 
of sarin exposure but may not be the only mode of cell death employed under such 
circumstances.  Caspase-3 expression, which definitively indicates apoptotic cell death, 
was significantly up-regulated in the piriform cortex 24 hours after acute sarin exposure.  
In contrast with our TUNEL results, the CA1 hippocampal region displayed significant 
caspase-3 activity four days after sarin injection.  Dentate gyrus and amygdala did not 
show any significant caspase-3 activity.  It would be beneficial to increase the number of 
timepoints examined early after sarin injection in order to determine the interplay and 
precise temporal arrangement of caspase-3 activity and TUNEL labeling in addition to 
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identifying the ideal time at which cell death could be targeted for therapeutic 
intervention.    
Although the caspase-3 activity detected in our samples underwent an initial 
increase followed by a gradual decrease, IL-1β staining was indicative of a gradual 
increase in inflammatory activity following sarin exposure.  Amygdala, dentate gyrus and 
CA1 hippocampal regions are susceptible to neuroinflammation as a result of sarin 
exposure, indicated by significant increases in IL-1β expression.  The potential 
therapeutic value of 8-OH-DPAT was demonstrated by the significant decreases in IL-1β 
expression observed in the amygdala and dentate gyrus regions at ten days after sarin and 
8-OH-DPAT injection.  We suspect that the efficacy of 8-OH-DPAT treatment lies in its 
ability to attenuate glutamate release, thereby putting an end to seizure activity due to 
NMDA receptor stimulation.   
 Our TUNEL data indicate that there is a gradual increase in cell death over time 
after an acute exposure to sarin in the dentate gyrus, CA1 and piriform cortex regions.  
Although none of these values reached statistical significance, it is possible that they may 
at later time points.  A similar increase in inflammation was observed in all regions 
except CA1 hippocampus.  This correlation indicates that cell death, accompanied by an 
inflammatory response may be a persistent threat to neuronal function beyond ten days 
after an acute exposure to sarin.  This observation is corroborated by Chapman and 
colleagues (2006), who reported that significantly up-regulated inflammatory cytokines 
were still detectable up to 30 days beyond a single exposure to sarin.  Effector caspase 
activity, on the other hand, after an early peak at four or 24 hours post-exposure, 
gradually decreases over time, while TUNEL labeling of dying cells gradually increases.  
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This could be indicative of a shift from primarily apoptotic cell death to oncotic cell 
death as time progresses. 
 Further research should be done to obtain conclusive results on the temporal 
progression of cell death and inflammation in this model of sarin exposure.  The time 
course should be extended in order to determine when neurodegeneration and 
neuroinflammation peak and the therapeutic value of 8-OH-DPAT should be examined at 
corresponding time points.  Unfortunately, the ten day post-treatment time point was not 
optimal in all cases, and therefore the apparent ineffectiveness of 8-OH-DPAT treatment 
may be misleading.  If all time points had been examined with 8-OH-DPAT treatment, 
more significant results may have been observed.  It would also be beneficial to include 
more early time points to determine if there is a peak time during which apoptosis occurs 
in response to sarin exposure, possibly providing an additional therapeutic window.  This 
work would create a broader view of the toxicity associated with sarin exposure and have 
applications in defense against terrorism and chemical warfare.  These preliminary results 
indicate that 8-OH-DPAT may be an effective therapy against the neuroinflammation that 
occurs as a result of exposure to nerve agents.  More work must be done at appropriately 
chosen timepoints in order to determine the efficacy of 8-OH-DPAT treatment against 
neuronal cell death.       
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V.  APPENDIX 
 
  No. of Sections Counted  
Animal 
Number 
Dentate 
Gyrus   Amygdala CA1 
Piriform 
Cortex 
155 1 1 1 1 
156 1 1 1 1 Positive Controls 
193 1 1 1 1 
155 2 2 2 2 
156 2 2 2 2 
178 1 1 1 1 
Negative Controls 
193 2 2 2 2 
130 1 1 1 1 
131 1 1 1 1 
132 1 1 1 1 
CBDP Only 4 Hours 
Post-Treatment 
133 1 1 1 1 
158 2 2 2 2 Sarin + CBDP 4 Hours 
Post-Treatment 159 1 1 1 1 
210 2 2 2 2 Sarin + CBDP 24 Hours 
Post-Treatment 212 2 2 2 2 
146 1 1 1 1 
147 1 1 1 1 
148 1 1 1 1 
Sarin + CBDP 96 Hours 
Post-Treatment 
149 1 1 1 1 
175 0 2 2 2 
177 1 1 1 1 
185 1 1 1 1 
189 1 1 1 1 
Sarin + CBDP 240 
Hours Post-Treatment 
192 0 1 1 1 
219 1 1 1 1 
220 1 1 1 1 
221 1 1 1 1 
222 1 1 1 1 
224 1 1 1 1 
Sarin + CBDP + 8-OH-
DPAT 240 Hours Post-
Treatment 
225 1 1 1 1 
 
TABLE 1.  Number of Sections Assessed for TUNEL Labeling: This table summarizes 
the number of sections that were TUNEL-labeled and counted for each animal within the 
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experimental groups.  Positive controls were stained to confirm that the assay protocol 
was performed properly, however counts were not included in the statistical analysis.  
Counts from multiple sections from each animal were averaged to obtain a mean cell 
count for each region.  Regions with 0 sections counted (gray boxes) were disregarded as 
a result of damage to the section making an accurate cell count impossible. 
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  No. of Sections Counted  
Animal 
Number 
Dentate 
Gyrus   Amygdala CA1 
Piriform 
Cortex 
180 2 2 2 2 
181 2 2 2 2 
184 2 2 2 2 
Negative Controls 
193 2 2 2 2 
130 2 2 2 2 
131 2 2 2 2 
132 2 2 2 2 
CBDP Only 4 Hours 
Post-Treatment 
133 2 2 2 2 
158 2 2 2 2 Sarin + CBDP 4 Hours 
Post-Treatment 159 2 2 2 1 
210 2 2 2 2 Sarin + CBDP 24 Hours 
Post-Treatment 212 2 2 2 2 
146 2 2 2 2 
153 2 2 2 2 
154 2 2 2 2 
Sarin + CBDP 96 Hours 
Post-Treatment 
161 2 2 2 2 
174 1 1 1 1 
177 2 2 2 2 
185 2 2 2 2 
189 2 2 2 2 
Sarin + CBDP 240 
Hours Post-Treatment 
0 2 2 2 192 
219 2 2 2 2 
220 2 2 2 2 
221 0 2 2 2 
222 2 2 2 2 
224 2 1 2 2 
Sarin + CBDP + 8-OH-
DPAT 240 Hours Post-
Treatment 
225 2 2 1 2 
    
TABLE 2.  Number of Sections assessed for Caspase-3 Labeling: This table summarizes 
the number of sections that were caspase-stained and counted for each animal within the 
experimental groups.  Counts from multiple sections from each animal were averaged to 
obtain a mean cell count for each region.  Regions with 0 sections counted (gray boxes) 
were disregarded as a result of damage to the section making an accurate cell count 
impossible. 
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  No. of Sections Counted  
Animal 
Number 
Dentate 
Gyrus   Amygdala CA1 
Piriform 
Cortex 
180 2 2 2 2 
181 2 1 2 2 
184 2 1 1 2 
Negative Controls 
193 2 2 2 2 
130 1 2 2 2 
131 2 2 2 2 
132 2 2 2 2 
CBDP Only 4 Hours 
Post-Treatment 
133 2 2 2 2 
158 2 2 2 2 Sarin + CBDP 4 Hours 
Post-Treatment 159 2 2 2 2 
210 2 2 2 2 Sarin + CBDP 24 Hours 
Post-Treatment 212 2 2 2 2 
144 2 2 2 2 
145 1 2 2 2 
146 2 2 2 2 
147 1 2 2 2 
Sarin + CBDP 96 Hours 
Post-Treatment 
148 2 2 2 1 
149 2 2 2 2 
175 2 1 1 2 
177 1 2 2 2 
185 2 2 2 1 
189 2 2 2 2 
Sarin + CBDP 240 
Hours Post-Treatment 
192 2 2 2 2 
219 1 2 2 2 
220 2 2 2 2 
221 1 1 1 1 
222 1 1 1 2 
224 2 2 2 2 
Sarin + CBDP + 8-OH-
DPAT 240 Hours Post-
Treatment 
225 2 2 2 2 
 
TABLE 3.  Number of Sections Assessed for IL-1β Labeling: This table summarizes the 
number of sections that were stained for IL-1β and counted for each animal within the 
experimental groups.  Counts from multiple sections from each animal were averaged to 
obtain a mean cell count for each region.   
   
 56
 
 
VI.  REFERENCES 
1. Abdel-Rahman, A., A.K. Shetty, and M.B. Abou-Donia, Acute exposure to sarin 
increases blood brain barrier permeability and induces neuropathological changes 
in the rat brain: dose-response relationships. Neuroscience, 2002. 113(3): p. 721-
41. 
2. Adayev, T., et al., Agonist stimulation of the serotonin1A receptor causes 
suppression of anoxia-induced apoptosis via mitogen-activated protein kinase in 
neuronal HN2-5 cells. J Neurochem, 1999. 72(4): p. 1489-96. 
3. Basu, A., J.K. Krady, and S.W. Levison, Interleukin-1: a master regulator of 
neuroinflammation. J Neurosci Res, 2004. 78(2): p. 151-6. 
4.  Basu, A., et al., Interleukin-1 and the interleukin-1 type 1 receptor are essential 
for the progressive neurodegeneration that ensues subsequent to a mild 
hypoxic/ischemic injury.  J Cereb Blood Flow Metab, 2005.  25:p.17-29. 
5. Carlson, K. and M. Ehrich, Organophosphorus compound-induced delayed 
neurotoxicity in white leghorn hens assessed by Fluoro-Jade. Int J Toxicol, 2004. 
23(4): p. 259-66. 
6. Chalmers, D.T. and S.J. Watson, Comparative anatomical distribution of 5-HT1A 
receptor mRNA and 5-HT1A binding in rat brain--a combined in situ 
hybridisation/in vitro receptor autoradiographic study. Brain Res, 1991. 561(1): p. 
51-60. 
 57
7. Chapman, S., T. Kadar, and E. Gilat, Seizure duration following sarin exposure 
affects neuro-inflammatory markers in the rat brain. Neurotoxicology, 2006. 
27(2): p. 277-83. 
8. Colino, A. and J.V. Halliwell, Differential modulation of three separate K-
conductances in hippocampal CA1 neurons by serotonin. Nature, 1987. 
328(6125): p. 73-7. 
9. Damodaran, T.V., et al., Toxicogenomic studies of the rat brain at an early time 
point  following acute sarin exposure. Neurochem Res, 2006. 31(3): p. 367-81. 
10. Davies, C.A., et al., The progression and topographic distribution of interleukin-
1beta  expression after permanent middle cerebral artery occlusion in the rat. J 
Cereb Blood Flow Metab, 1999. 19(1): p. 87-98. 
11. Dong, Z., et al., Internucleosomal DNA cleavage triggered by plasma membrane 
damage during necrotic cell death. Involvement of serine but not cysteine 
proteases. Am J Pathol, 1997. 151(5): p. 1205-13. 
12. Fargin, A., et al., Effector coupling mechanisms of the cloned 5-HT1A receptor. J 
Biol  Chem, 1989. 264(25): p. 14848-52. 
13. Fietta, P., Many ways to die: passive and active cell death styles. Riv Biol, 2006. 
99(1): p. 69-83. 
14. Gupta, R.C., G.T. Patterson, and W.D. Dettbarn, Acute tabun toxicity; 
biochemical and histochemical consequences in brain and skeletal muscles of rat. 
Toxicology, 1987. 46(3): p. 329-41. 
15. Henderson, R.F., et al., Response of rats to low levels of sarin. Toxicol Appl 
Pharmacol, 2002. 184(2): p. 67-76. 
 58
16. Hoskins, B., et al., Relationship between the neurotoxicities of Soman, Sarin and 
Tabun, and acetylcholinesterase inhibition. Toxicol Lett, 1986. 30(2): p. 121-9. 
17. Kline, A.E., et al., The selective 5-HT(1A) receptor agonist repinotan HCl 
attenuates histopathology and spatial learning deficits following traumatic brain 
injury in rats. Neuroscience, 2001. 106(3): p. 547-55. 
18. Liu, Y.F. and P.R. Albert, Cell-specific signaling of the 5-HT1A receptor. 
Modulation by protein kinases C and A. J Biol Chem, 1991. 266(35): p. 23689-
97. 
19. Majno, G. and I. Joris, Apoptosis, oncosis, and necrosis. An overview of cell 
death. Am J Pathol, 1995. 146(1): p. 3-15. 
20. Maxwell, D.M., K.M. Brecht, and B.L. O'Neill, The effect of carboxylesterase 
inhibition on interspecies differences in soman toxicity. Toxicol Lett, 1987. 39(1): 
p. 35-42. 
21. McDonough, J.H., Jr. and T.M. Shih, Neuropharmacological mechanisms of 
nerve agent- induced seizure and neuropathology. Neurosci Biobehav Rev, 
1997. 21(5): p. 559-79. 
22. McGeer, P.L. and E.G. McGeer, The inflammatory response system of brain: 
implications for therapy of Alzheimer and other neurodegenerative diseases. 
Brain Res Brain Res Rev, 1995. 21(2): p. 195-218. 
23. McLean, M.J., et al., Prophylactic and therapeutic efficacy of memantine against 
seizures produced by soman in the rat. Toxicol Appl Pharmacol, 1992. 112(1): p. 
95-103. 
 59
24. McLin, J.P. and O. Steward, Comparison of seizure phenotype and 
neurodegeneration induced by systemic kainic acid in inbred, outbred, and hybrid 
mouse strains. Eur J Neurosci, 2006. 24(8): p. 2191-202. 
25. Medical management guidelines for nerve agents tabun (GA); sarin (GB); soman 
(GD); and VX., in Centers for Disease Control and Prevention. 2003, Agency for 
Toxic Substances and Disease Registry. 
26. Munro, N., Toxicity of the Organophosphate Chemical Warfare Agents GA, GB, 
and VX: Implications for Public Protection. Environ Health Perspect, 1994. 
102(1): p. 18-37. 
27. Nyakas, C., et al., Selective decline of 5-HT1A receptor binding sites in rat 
cortex, hippocampus and cholinergic basal forebrain nuclei during aging. J Chem 
Neuroanat, 1997. 13(1): p. 53-61. 
28. Ohman, J., R. Braakman, and V. Legout, Repinotan (BAY x 3702): a 5HT1A 
agonist in traumatically brain injured patients. J Neurotrauma, 2001. 18(12): p. 
1313-21. 
29. Okumura, T., et al., The Tokyo subway sarin attack: disaster management, Part 1: 
Community emergency response. Acad Emerg Med, 1998. 5(6): p. 613-7. 
30. Oosterink, B.J., T. Harkany, and P.G. Luiten, Post-lesion administration of 5-
HT1A  receptor agonist 8-OH-DPAT protects cholinergic nucleus basalis neurons 
against NMDA excitotoxicity. Neuroreport, 2003. 14(1): p. 57-60. 
31. Prehn, J.H., et al., Effects of serotonergic drugs in experimental brain ischemia: 
evidence for a protective role of serotonin in cerebral ischemia. Brain Res, 1993. 
630(1-2): p. 10-20. 
 60
32. Ramos, A.J., et al., The 5HT1A receptor agonist, 8-OH-DPAT, protects neurons 
and reduces astroglial reaction after ischemic damage caused by cortical 
devascularization. Brain Res, 2004. 1030(2): p. 201-20. 
33. Schmued, L.C., et al., Fluoro-Jade C results in ultra high resolution and contrast 
labeling of degenerating neurons. Brain Res, 2005. 1035(1): p. 24-31. 
34. Smith, M.I. and M. Deshmukh, Endoplasmic reticulum stress-induced apoptosis 
requires bax for commitment and Apaf-1 for execution in primary neurons. Cell 
Death Differ, 2007. 14(5): p. 1011-9. 
35. Srkalovic, G., et al., Serotonergic inhibition of extracellular glutamate in the 
suprachiasmatic nuclear region assessed using in vivo brain microdialysis. Brain 
Res, 1994. 656(2): p. 302-8. 
36. Steward, O., et al., Neuronal activity up-regulates astroglial gene expression. Proc 
Natl Acad Sci U S A, 1991. 88(15): p. 6819-23. 
37. Svensson, I., et al., Soman-induced interleukin-1 beta mRNA and protein in rat 
brain. Neurotoxicology, 2001. 22(3): p. 355-62. 
38. Tanaka, K., S.H. Graham, and R.P. Simon, The role of excitatory 
neurotransmitters in seizure-induced neuronal injury in rats. Brain Res, 1996. 
737(1-2): p. 59-63. 
39. Tokuda, Y., et al., Prehospital management of sarin nerve gas terrorism in urban 
settings: 10 years of progress after the Tokyo subway sarin attack. Resuscitation, 
2006. 68(2): p. 193-202. 
40. Trump, B.F., et al., The pathways of cell death: oncosis, apoptosis, and necrosis. 
Toxicol Pathol, 1997. 25(1): p. 82-8. 
 61
41. Tu, B. and N.G. Bazan, Hippocampal kindling epileptogenesis upregulates 
neuronal cyclooxygenase-2 expression in neocortex. Exp Neurol, 2003. 179(2): p. 
167-75. 
42. Williams, A.J., et al., Central neuro-inflammatory gene response following soman 
exposure in the rat. Neurosci Lett, 2003. 349(3): p. 147-50. 
43. Wood, P.L., Microglia: Roles of microglia in chronic neurodegenerative diseases, 
in Neuroinflammation: Mechanisms and Management, P.L. Wood, Editor. 2003, 
Humana Press: Totowa, NJ. p. 3-27. 
44. Wyllie, A.H., Apoptosis: an overview. Br Med Bull, 1997. 53(3): p. 451-65. 
45. Wyllie, A.H., G.J. Beattie, and A.D. Hargreaves, Chromatin changes in apoptosis. 
Histochem J, 1981. 13(4): p. 681-92. 
46. Zimmer, L.A., M. Ennis, and M.T. Shipley, Soman-induced seizures rapidly 
activate astrocytes and microglia in discrete brain regions. J Comp Neurol, 1997. 
378(4): p. 482-92. 
 
 
 
 
 
 
 
 
 
 62
